Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

Source:http://linkedlifedata.com/resource/pubmed/id/18451240

Clin. Cancer Res. 2008 May 1 14 9 2740-8

Download in:

View as

General Info

PMID
18451240